131 related articles for article (PubMed ID: 12477322)
21. Fusidic acid cream for impetigo. Emergence of resistance to fusidic acid limits its use.
Weston VC; Boswell TC; Finch RG; Perkins W
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053928
[No Abstract] [Full Text] [Related]
22. Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.
Deplano A; Hallin M; Bustos Sierra N; Michel C; Prevost B; Martiny D; Yin N
J Antimicrob Chemother; 2023 Aug; 78(8):2061-2065. PubMed ID: 37358399
[TBL] [Abstract][Full Text] [Related]
23. [Outburst of fusidic acid resistant Staphylococcus aureus].
Kanazaki H; Akiyama H; Kanamoto A; Abe Y; Yamada T; Arata J; Umemura S; Ikeda M
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):507-10. PubMed ID: 2614994
[TBL] [Abstract][Full Text] [Related]
24. An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant
Vendrik KEW; Kuijper EJ; Dimmendaal M; Silvis W; Denie-Verhaegh E; de Boer A; Postma B; Schoffelen AF; Ruijs WLM; Koene FMHPA; Petrignani M; Hooiveld M; Witteveen S; Schouls LM; Notermans DW;
Euro Surveill; 2022 Dec; 27(49):. PubMed ID: 36695440
[TBL] [Abstract][Full Text] [Related]
25. Fusidic acid cream for impetigo. Findings cannot be extrapolated.
Owen SE; Cheesbrough JS
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053931
[No Abstract] [Full Text] [Related]
26. Fusidic acid cream for impetigo. Problem may be clinically important.
Stoddart B; Collyns T; Denton M
BMJ; 2002 Jun; 324(7350):1394. PubMed ID: 12053929
[No Abstract] [Full Text] [Related]
27. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.
O'Neill AJ; Larsen AR; Skov R; Henriksen AS; Chopra I
J Clin Microbiol; 2007 May; 45(5):1505-10. PubMed ID: 17344365
[TBL] [Abstract][Full Text] [Related]
28. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus.
Howden BP; Grayson ML
Clin Infect Dis; 2006 Feb; 42(3):394-400. PubMed ID: 16392088
[TBL] [Abstract][Full Text] [Related]
29. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
Vogel A; Lennon D; Best E; Leversha A
N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
[TBL] [Abstract][Full Text] [Related]
30. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
[TBL] [Abstract][Full Text] [Related]
31. Nasal carriage and antibiotic susceptibility of Staphylococcus aureus in general practice.
Gillett AP; Johnson T; Orton C; Wills R; Menday AP; Talbot DJ
J R Coll Gen Pract; 1984 May; 34(262):255-7. PubMed ID: 6737360
[TBL] [Abstract][Full Text] [Related]
32. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
Rørtveit S; Rortveit G
Br J Dermatol; 2007 Jul; 157(1):100-5. PubMed ID: 17553056
[TBL] [Abstract][Full Text] [Related]
33. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital.
Naas T; Fortineau N; Spicq C; Robert J; Jarlier V; Nordmann P
J Hosp Infect; 2005 Dec; 61(4):321-9. PubMed ID: 16026895
[TBL] [Abstract][Full Text] [Related]
34. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
[TBL] [Abstract][Full Text] [Related]
35. [An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002].
Rørtveit S; Rørtveit G
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2557-60. PubMed ID: 14714041
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of community-acquired methicillin-susceptible and resistant Staphylococcus aureus isolates recovered from bacteraemic and osteomyelitis infections in children from Tunisia.
Kechrid A; Pérez-Vázquez M; Smaoui H; Hariga D; Rodríguez-Baños M; Vindel A; Baquero F; Cantón R; Del Campo R
Clin Microbiol Infect; 2011 Jul; 17(7):1020-6. PubMed ID: 20977540
[TBL] [Abstract][Full Text] [Related]
37. A clonal outbreak of methicillin-susceptible Staphylococcus aureus with concomitant resistance to erythromycin, clindamycin and tobramycin in a Swedish county.
Lindqvist M; Isaksson B; Samuelsson A; Nilsson LE; Hallgren A
Scand J Infect Dis; 2009; 41(5):324-33. PubMed ID: 19294581
[TBL] [Abstract][Full Text] [Related]
38. Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus.
Price CT; O'Brien FG; Shelton BP; Warmington JR; Grubb WB; Gustafson JE
J Antimicrob Chemother; 1999 Jul; 44(1):57-64. PubMed ID: 10459810
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility testing and clinical effect of fusidic acid in oxacillin-resistant Staphylococcus aureus infections.
Liu CP; Lee CM; Su SC; Li YT
J Microbiol Immunol Infect; 1999 Sep; 32(3):194-8. PubMed ID: 10637718
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance of Staphylococcus aureus isolated from impetigo patients between 1994 and 2000.
Nishijim S; Ohshima S; Higashida T; Nakaya H; Kurokawa I
Int J Dermatol; 2003 Jan; 42(1):23-5. PubMed ID: 12581136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
